Emerging concepts in Alzheimer's disease.
暂无分享,去创建一个
[1] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[2] C. van Broeckhoven,et al. Frontotemporal Lobar Degeneration: Current Concepts in the Light of Recent Advances , 2007 .
[3] Chris Zarow,et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology , 2006, Annals of neurology.
[4] J. Growdon,et al. Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease , 2012, Journal of neuropathology and experimental neurology.
[5] S. Resnick,et al. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of aging cohort , 2010, Annals of neurology.
[6] J. Touchon,et al. Mild cognitive impairment: conceptual basis and current nosological status , 2000, The Lancet.
[7] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[8] S. Leurgans,et al. Neurodegenerative basis of age-related cognitive decline , 2010, Neurology.
[9] O. Lopez,et al. Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study , 2012, Acta Neuropathologica.
[10] D. Selkoe,et al. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases , 1988, Annals of neurology.
[11] Biomarkers and brain connectivity. , 2013, JAMA neurology.
[12] Clifford R. Jack,et al. Alliance for Aging Research AD Biomarkers Work Group: structural MRI , 2011, Neurobiology of Aging.
[13] H. Braak,et al. Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.
[14] H. Budka,et al. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics , 2010, Acta Neuropathologica.
[15] H. Vinters,et al. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. , 1990, The American journal of pathology.
[16] L. Mucke,et al. Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.
[17] D. Dickson,et al. Hippocampal sclerosis dementia differs from hippocampal sclerosis in frontal lobe degeneration , 2006, Acta Neuropathologica.
[18] David A Wolk,et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. , 2012, Brain : a journal of neurology.
[19] T. Montine,et al. Novel Antibody Capture Assay for Paraffin‐Embedded Tissue Detects Wide‐Ranging Amyloid Beta and Paired Helical Filament–Tau Accumulation in Cognitively Normal Older Adults , 2012, Brain pathology.
[20] S. DeKosky,et al. Amyloid imaging in dementias with atypical presentation , 2012, Alzheimer's & Dementia.
[21] H. Vinters,et al. Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease , 1996, Brain pathology.
[22] S. Love,et al. A&bgr;-Degrading Enzymes: Potential for Treatment of Alzheimer Disease , 2011, Journal of neuropathology and experimental neurology.
[23] Nick C Fox,et al. Assessing the onset of structural change in familial Alzheimer's disease , 2003, Annals of neurology.
[24] R. Tanzi,et al. TREM2 and neurodegenerative disease. , 2013, The New England journal of medicine.
[25] M. Sabbagh,et al. The biochemical aftermath of anti-amyloid immunotherapy , 2010, Molecular Neurodegeneration.
[26] M. Spillantini,et al. Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations , 2007, Brain pathology.
[27] Miranka Wirth,et al. Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals , 2013, The Journal of Neuroscience.
[28] E. Bigio. Update on Recent Molecular and Genetic Advances in Frontotemporal Lobar Degeneration , 2008, Journal of neuropathology and experimental neurology.
[29] Mathias Jucker,et al. Mechanism of Cerebral β‐Amyloid Angiopathy: Murine and Cellular Models , 2006 .
[30] J. Cummings,et al. Comorbidity in dementia: an autopsy study. , 2004, Archives of pathology & laboratory medicine.
[31] K. Jellinger. The pathology of "vascular dementia": a critical update. , 2008, Journal of Alzheimer's disease : JAD.
[32] H. Vinters,et al. Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy , 2010, Brain pathology.
[33] H. Budka,et al. Current concepts of neuropathological diagnostics in practice: neurodegenerative diseases. , 2010, Clinical neuropathology.
[34] P. Davies,et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (≥80 years of age) humans , 2004, Acta Neuropathologica.
[35] Practical utility of amyloid and FDG-PET in an academic dementia center , 2014, Neurology.
[36] M. Weiner,et al. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia , 2005, Annals of neurology.
[37] S. DeKosky,et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease , 2008, Brain : a journal of neurology.
[38] M. Mintun,et al. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β‐amyloid , 2013, Annals of neurology.
[39] A. Brun,et al. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.
[40] D. Bennett,et al. Where Vascular Meets Neurodegenerative Disease , 2010, Stroke.
[41] H. Vinters,et al. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. , 1983, Stroke.
[42] T. Montine,et al. Associations Between Microinfarcts and Other Macroscopic Vascular Findings on Neuropathologic Examination in 2 Databases , 2009, Alzheimer disease and associated disorders.
[43] G. Bitan,et al. Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases , 2012, Springer Netherlands.
[44] H. Vinters,et al. Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study. , 1994, Ultrastructural pathology.
[45] H. Vinters,et al. Immunohistochemical study of cerebral amyloid angiopathy: use of an antiserum to a synthetic 28-amino-acid peptide fragment of the Alzheimer's disease amyloid precursor. , 1988, Human pathology.
[46] Ge Li,et al. Neuropathology in the adult changes in thought study: a review. , 2009, Journal of Alzheimer's disease : JAD.
[47] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[48] John Hardy,et al. Antiamyloid therapy for Alzheimer's disease--are we on the right road? , 2014, The New England journal of medicine.
[49] L A Hansen,et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.
[50] J. Attems,et al. Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain , 2012, Experimental Gerontology.
[51] D. Knopman,et al. Cerebrovascular disease and dementia. , 2007, The British journal of radiology.
[52] Stephen J. DeArmond,et al. Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions , 2012, Proceedings of the National Academy of Sciences.
[53] T. Erkinjuntti,et al. Large Vessel Cerebral Atherosclerosis Is Not in Direct Association with Neuropathological Lesions of Alzheimer’s Disease , 2009, European Neurology.
[54] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[55] Julie A. Harris,et al. Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network , 2010, Neuron.
[56] R. Deane,et al. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. , 2007, Current Alzheimer research.
[57] Nick C Fox,et al. Rates of global and regional cerebral atrophy in AD and frontotemporal dementia , 2001, Neurology.
[58] Bernardino Ghetti,et al. Alois Alzheimer: His Life and Times , 2007, Brain pathology.
[59] W. Jagust,et al. Effect of Cognitive Reserve Markers on Alzheimer Pathologic Progression , 2013, Alzheimer disease and associated disorders.
[60] J. Mazziotta,et al. Early Detection of Alzheimer's Disease by Combining Apolipoprotein E and Neuroimaging a , 1996, Annals of the New York Academy of Sciences.
[61] Yvonne S. Eisele,et al. The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain , 2011, Acta Neuropathologica.
[62] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[63] W. Jagust. Apolipoprotein E, neurodegeneration, and Alzheimer disease. , 2013, JAMA neurology.
[64] William J. Jagust,et al. Brain imaging in the study of Alzheimer's disease , 2012, NeuroImage.
[65] R Brookmeyer,et al. Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.
[66] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[67] D. Dickson,et al. The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.
[68] J. Schneider,et al. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease , 2012, Alzheimer's & Dementia.
[69] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[70] M. Ball. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients. A quantitative study , 1978, Acta Neuropathologica.
[71] P. Hof,et al. The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease , 2013, Neuropathology and applied neurobiology.
[72] J. Attems,et al. Capillary CAA and perivascular Aβ-deposition: Two distinct features of Alzheimer's disease pathology , 2010, Journal of the Neurological Sciences.
[73] H. Vinters. Imaging cerebral microvascular amyloid , 2007, Annals of neurology.
[74] S. Black,et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[75] John L. Robinson,et al. Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. , 2011, Brain : a journal of neurology.
[76] H. Vinters,et al. A morphometric study of the blood-brain barrier in Alzheimer's disease. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[77] R. Kalaria,et al. Amyloid-?? and synaptic activity in mice and men , 2007 .
[78] B. Hyman,et al. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. , 2012, The American journal of pathology.
[79] D. Selkoe,et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.
[80] M. Kidd. Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease , 1963, Nature.
[81] H. Hampel,et al. Biomarkers in the Diagnosis of Alzheimer’s Disease: Are We Ready? , 2006, Journal of geriatric psychiatry and neurology.
[82] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[83] C. Iadecola. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia , 2010, Acta Neuropathologica.
[84] L. Mucke,et al. Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.
[85] Dietmar R. Thal,et al. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.
[86] S. D. Preston,et al. Cerebrovascular Disease Is a Major Factor in the Failure of Elimination of Aβ from the Aging Human Brain , 2002 .
[87] S. Leurgans,et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons , 2011, Annals of neurology.
[88] K. Jellinger,et al. Alzheimer disease and cerebrovascular pathology: an update , 2002, Journal of Neural Transmission.
[89] H. Vinters. Cerebral amyloid angiopathy. A critical review. , 1987, Stroke.
[90] K. Jellinger,et al. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.
[91] M. Daly,et al. Variant TREM2 as risk factor for Alzheimer's disease. , 2013, The New England journal of medicine.
[92] J. Cummings,et al. Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy. , 1999, Archives of neurology.
[93] Mark E. Schmidt,et al. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[94] M. Ball,et al. Intracerebral propagation of Alzheimer’s disease: Strengthening evidence of a herpes simplex virus etiology , 2013, Alzheimer's & Dementia.
[95] Martin Beibel,et al. Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.
[96] Matthew P. Frosch,et al. Plasma A&bgr; Levels Do Not Reflect Brain A&bgr; Levels , 2007 .
[97] G. Schellenberg,et al. The genetics and neuropathology of Alzheimer’s disease , 2012, Acta Neuropathologica.
[98] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[99] Gina N. LaRossa,et al. [11C]PIB in a nondemented population , 2006, Neurology.
[100] C. Holmes,et al. Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report , 2003, Nature Medicine.
[101] H. Chui,et al. Understanding hippocampal sclerosis in the elderly: Epidemiology, characterization, and diagnostic issues , 2008, Current neurology and neuroscience reports.
[102] J. Provias,et al. The case for blood–brain barrier dysfunction in the pathogenesis of Alzheimer's disease , 2011, Journal of neuroscience research.
[103] O. Selnes,et al. Vascular cognitive impairment , 2006, Nature Clinical Practice Neurology.
[104] H. Braak,et al. Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: A third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques , 1986, Neuroscience Letters.
[105] O. Wiestler,et al. Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.
[106] C. Holmes,et al. Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis , 2010, Acta Neuropathologica.
[107] G. Halliday,et al. Variations in the neuropathology of familial Alzheimer’s disease , 2009, Acta Neuropathologica.
[108] I. Ferrer,et al. A&bgr; Species Removal After A&bgr;42 Immunization , 2006, Journal of neuropathology and experimental neurology.
[109] Giuliano Binetti,et al. Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future , 2011, Neurodegenerative Diseases.
[110] K. Jellinger,et al. Prevalence of dementia disorders in the oldest-old: an autopsy study , 2010, Acta Neuropathologica.
[111] H. Wiśniewski,et al. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia , 1979, Annals of neurology.
[112] H. Vinters,et al. Hypoxia and reoxygenation of brain microvascular smooth muscle cells in vitro: cellular responses and expression of cerebral amyloid angiopathy‐associated proteins , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[113] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[114] Lawrence Rajendran,et al. The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids , 2009, Neuron.
[115] C. Holmes,et al. Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization. , 2013, Brain : a journal of neurology.
[116] E. Masliah,et al. Transgenic animal models of neurodegenerative diseases and their application to treatment development. , 2007, Advanced drug delivery reviews.
[117] D. Berlau,et al. Dissociation of Neuropathologic Findings and Cognition: Case Report of an Apolipoprotein E ε2/ε2 Genotype , 2007 .
[118] Hwamee Oh,et al. Association of gray matter atrophy with age, β-amyloid, and cognition in aging. , 2014, Cerebral cortex.
[119] K. Langa,et al. Mixed dementia: emerging concepts and therapeutic implications. , 2004, JAMA.
[120] E. Tangalos,et al. Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.
[121] R. Coleman,et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study , 2012, The Lancet Neurology.
[122] H. Vinters,et al. High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease. , 2010, Human pathology.
[123] V. Hachinski,et al. A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA , 1985, The Lancet.
[124] D. Connor,et al. Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles , 2006, Acta Neuropathologica.
[125] I. Ferrer,et al. Neuropathology and Pathogenesis of Encephalitis following Amyloid β Immunization in Alzheimer's Disease , 2004, Brain pathology.
[126] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[127] Dennis W Dickson,et al. Progressive Supranuclear Palsy: Pathology and Genetics , 2007, Brain pathology.
[128] H. Braak,et al. Neuropil Threads Occur in Dendrites of Tangle—Bearing Nerve Cells , 1988, Neuropathology and applied neurobiology.
[129] George Perry,et al. The complexities of the pathology-pathogenesis relationship in Alzheimer disease. , 2014, Biochemical pharmacology.
[130] M. Ball,et al. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia , 1977, Acta Neuropathologica.
[131] T. Montine,et al. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis , 2010, Journal of Neural Transmission.
[132] H. Mori,et al. Inverse correlation between amyloid precursor protein and synaptic plasticity in transgenic mice , 2007, Neuroreport.
[133] S. Black,et al. National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.
[134] H. Vinters. Neuropathology of amnestic mild cognitive impairment. , 2006, Archives of neurology.
[135] L. Thal,et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease , 1996, Neurology.
[136] K. Blennow,et al. Neurochemical Dissection of Synaptic Pathology in Alzheimer's Disease , 1998, International Psychogeriatrics.
[137] Jason J. Corneveaux,et al. Initial Assessment of the Pathogenic Mechanisms of the Recently Identified Alzheimer Risk Loci , 2013, Annals of human genetics.
[138] R. Petersen,et al. Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease , 2007 .
[139] K. Jellinger,et al. Neuropathological evaluation of mixed dementia , 2007, Journal of the Neurological Sciences.
[140] V. Poukens,et al. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia , 1994, Acta Neuropathologica.
[141] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[142] M. Frosch,et al. The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic , 2006 .
[143] J. Vickers,et al. Vaccination Strategies for Alzheimer’s Disease , 2007, Drugs & aging.
[144] H. Vinters,et al. Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. , 1997, Human pathology.
[145] D. Dickson,et al. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2011 .
[146] P. Mischel,et al. Cerebral Cortical Dysplasia Associated with Pediatric Epilepsy. Review of Neuropathologic Features and Proposal for a Grading System , 1995, Journal of neuropathology and experimental neurology.
[147] Ole A. Andreassen,et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.
[148] E. Siemers,et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.
[149] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[150] Richard J. Kryscio,et al. Alzheimer’s disease is not “brain aging”: neuropathological, genetic, and epidemiological human studies , 2011, Acta Neuropathologica.
[151] Nick C Fox,et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.
[152] Lawrence S. Honig,et al. Atherosclerosis and AD : Analysis of data from the US national Alzheimer's coordinating center. Author's reply , 2005 .
[153] E. Englund,et al. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia , 2006, International journal of geriatric psychiatry.
[154] K. Jellinger,et al. Cardiovascular diseases and hippocampal infarcts , 2011, Hippocampus.
[155] A. Nunomura,et al. Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.
[156] J. Growdon,et al. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.
[157] W. K. Cullen,et al. Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo , 2005, Nature Medicine.
[158] Seth Love,et al. Neuropathology: A Reference Text of CNS Pathology , 1998 .
[159] D. Selkoe,et al. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.
[160] R. Tibshirani,et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.
[161] J. Kaye,et al. Neuropathologic basis of age-associated brain atrophy. , 2013, JAMA neurology.
[162] E. Tangalos,et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. , 2006, Archives of neurology.
[163] S. Leurgans,et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.
[164] J. Trojanowski,et al. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease , 2013, Front. Ag. Neurosci..
[165] H. Chui,et al. Cerebral Atherosclerosis Is Associated With Cystic Infarcts and Microinfarcts but Not Alzheimer Pathologic Changes , 2013, Stroke.
[166] T. Miyakawa,et al. Ultrastructural studies of amyloid fibrils and senile plaques in human brain , 2004, Acta Neuropathologica.
[167] Seth Love,et al. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.
[168] P. Thompson,et al. PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.
[169] S. Leurgans,et al. Microinfarct Pathology, Dementia, and Cognitive Systems , 2011, Stroke.
[170] K. Jellinger,et al. The enigma of vascular cognitive disorder and vascular dementia , 2007, Acta Neuropathologica.
[171] William Jagust,et al. Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration , 2013, Neuron.
[172] H. Vinters,et al. A Shift in Microglial β‐Amyloid Binding in Alzheimer's Disease Is Associated with Cerebral Amyloid Angiopathy , 2013, Brain pathology.
[173] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.
[174] P. Thompson,et al. Pathologic lesions in neurodegenerative diseases. , 2012, Progress in molecular biology and translational science.
[175] H. Vinters,et al. Synapse loss in dementias , 2010, Journal of neuroscience research.
[176] H. Vinters,et al. Toxicity of Dutch (E22Q) and Flemish (A21G) mutant amyloid beta proteins to human cerebral microvessel and aortic smooth muscle cells. , 2000, Stroke.
[177] R O Weller,et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. , 2008, Brain : a journal of neurology.
[178] S. M. Sumi,et al. Clinical-neuropathologic findings in multi-infarct dementia , 1997, Neurology.
[179] W. Jagust,et al. Neuropathologic Substrates of Ischemic Vascular Dementia , 2000, Journal of neuropathology and experimental neurology.